Demyelinizing Neurological Disease after Treatment with Tumor Necrosis Factor-α Antagonists

Publisher： Karger

E-ISSN： 1663-2699|7|2|345-353

ISSN： 1663-2699

Source： Case Reports in Ophthalmology, Vol.7, Iss.2, 2016-07, pp. : 345-353

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aqueous Humor and Serum Tumor Necrosis Factor-α in Clinical Uveitis

By  

Ophthalmic Research, Vol. 33, Iss. 5, 2001-10 ,pp. : 251-255

Karger

Access to resources Recommend Favorite

CD5-Positive Primary Intraocular B-Cell Lymphoma Arising during Methotrexate and Tumor Necrosis Factor Inhibitor Treatment

By  

Case Reports in Ophthalmology, Vol. 6, Iss. 3, 2015-09 ,pp. : 301-306

Karger

Access to resources Recommend Favorite

Susceptibility to murine cytomegalovirus retinitis during progression of MAIDS: Correlation with intraocular levels of tumor necrosis factor- and interferon-&ggr;

By Dix Richard   Cousins Scott  

Current Eye Research, Vol. 29, Iss. 2-3, 2004-08 ,pp. : 173-180

Informa Healthcare

Access to resources Recommend Favorite

Expression of Tumor Necrosis Factor Alpha and Matrix Metalloproteinase-9 in Surgically Induced Necrotizing Scleritis

By  

Ophthalmic Research, Vol. 38, Iss. 2, 2006-03 ,pp. : 66-70

Karger

Access to resources Recommend Favorite

Blockade of Tumor Necrosis Factor-Alpha: A Role for Adalimumab in Neovascular Age-Related Macular Degeneration Refractory to Anti-Angiogenesis Therapy

By  

Case Reports in Ophthalmology, Vol. 7, Iss. 1, 2016-03 ,pp. : 154-162

Karger

Access to resources Recommend Favorite